Abdel Halim, PharmD, MSc, PhD, DABCC, FACB

Dr. Halim is a PharmD, PhD in Clinical Biochemistry and Cancer Molecular Biology, and one of only four lab professionals in the USA who are triple board certified in Clinical Chemistry, Molecular Diagnostics and Toxicology, and a fellow of the National Academy of Clinical Biochemistry (NACB).
Dr. Halim is the VP Translational Medicine, Biomarker and Diagnostics at Celldex Therapeutics, based in New Jersey, USA. In his current role, Dr. Halim is overseeing translational medicine including biomarker and target discovery, clinical biomarkers and diagnostics and their utilization in personalized medicine and companion diagnostics.
Before Celldex, he held multiple leadership positions in the pharmaceutical and diagnostic industries.Dr. Halim oversaw development and validation of 700+ assays and their applications in drug development and patient managements and led several CDx programs.
Dr. Halim has served on 15+ governmental and public expert panels and advisory groups covering different aspects in drug and diagnostic industries in the US, Canada and EU, and on 20+ committees to establish clinical laboratory and IVD guidelines to promote quality practices in the US and worldwide.
Abdel has 65 peer-reviewed publications and about 90 presentations including approximately 30 invited and keynote speeches in national and international meetings.